Squarepoint’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-54,501
Closed -$1.31M 4905
2025
Q2
$1.31M Buy
54,501
+29,762
+120% +$690K ﹤0.01% 2434
2025
Q1
$567K Buy
+24,739
New +$597K ﹤0.01% 3178
2024
Q3
Sell
-7,303
Closed -$216K 4617
2024
Q2
$217K Buy
+7,303
New +$203K ﹤0.01% 3618
2023
Q1
Sell
-8,534
Closed -$263K 3739
2022
Q4
$263K Buy
+8,534
New +$265K ﹤0.01% 2639

Other funds holding RTO

Squarepoint's RTO Position: Q3 2025 in Review

Squarepoint sold out of Rentokil (RTO) in Q3 2025, closing a stake of 54,501 shares — an estimated $1.31M sold.

Squarepoint first reported a position in RTO in Q4 2022 and held it in 4 quarters. The position peaked at $1.31M in Q2 2025. 213 funds tracked by Wall St. Rank hold RTO as of Q3 2025.

  • Squarepoint reported no remaining Rentokil position as of Q3 2025 after selling out during the quarter.
  • Squarepoint sold 54,501 Rentokil shares in Q3 2025, an estimated $1.31M.
  • Squarepoint first reported a position in Rentokil in Q4 2022 and held it in 4 quarters.
  • Squarepoint's Rentokil position peaked at $1.31M in Q2 2025.
  • 213 funds tracked by Wall St. Rank held Rentokil as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.